Individualizing Inhaled Therapies in COPD to Optimize Outcomes

Individualizing Inhaled Therapies in COPD to Optimize Outcomes is organized by Pri-Med.

Effective Date: 10/11/2019.
Expiration Date: 11/7/2020.

Credits:
•  1.00 AMA PRA Category 1 Credits™ or
•  1.00 AANP, including 0.42 AANP Pharm

Overview:
This interactive, discussion-based program led by a panel of expert faculty will review the latest GOLD guidelines recommendations and currently available inhaled therapies for the treatment of patients with COPD. In addition to considering risk factors for exacerbation, learners will identify COPD patients that are most likely to benefit from nebulized therapy and gain a thorough understanding of patient- and disease-specific factors that impact therapy and device selection for patients with COPD.

Topics:
Pulmonary Medicine, Chronic Obstructive Pulmonary Disease

Learning Objectives:
• Review inhaled treatment options available for patients with COPD
• Outline the risk factors associated with COPD exacerbation
• Identify COPD patients that are most likely to benefit from nebulized therapy
• Devise maintenance therapy for patients with COPD based on patient- and disease-specific characteristics

Additional details will be posted as soon as information is available.